Saved
Companies · Strategy

Mondelez International

2012

Mondelez didn’t reinvent snacking — it rebranded extraction.

Worth your time?3.5/5Yes.Study the whole thing.What works, what does not, who it is for ↓
11:11in productionCh. 1 · Roots, not revolution/ 11:11 · ceiling 15 min
6 chapters · 11:11Ceiling 15:00

The brief is written and checked. The video joins this page when it is cut.6 chapters · 1 min read · 11:11 planned

Read the brief

Mondelez International is a 2012 spin-off of Kraft Foods Inc., itself rooted in the 1923 National Dairy Products Corporation. It manufactures and sells branded snacks — cookies, chocolate, gum, biscuits, powdered beverages — in approximately 160 countries, generating about $38.5 billion in annual revenue. Its portfolio includes Oreo, Cadbury, Toblerone, Ritz, and Triscuit. It retains global snack assets while shedding North American grocery operations. It faces documented controversies over deforestation, child labour in cocoa sourcing, continued operations in Russia post-invasion, and antitrust penalties. Its business model relies on scale, brand equity, and geographic diversification — not product innovation or supply-chain transparency.

Chapters & takeaways6
  1. 0:54
    Roots, not revolution

    Mondelez is not a startup — it is the latest legal shell of a 100-year-old dairy conglomerate that evolved into snacks via acquisition and spin-off.

  2. 2:16
    What it actually makes

    It sells physical, branded, low-innovation consumables — cookies, chocolate, gum — not experiences, subscriptions, or data.

  3. 3:06
    Where the money comes from

    Revenue comes from scale, not novelty: $38.5 billion flows from 160 markets selling established brands with minimal R&D investment.

  4. 4:34
    What the split kept — and cut

    The 2012 split offloaded North American grocery — including processed cheese and frozen meals — leaving Mondelez with higher-margin, export-ready snacks.

  5. 5:43
    Ownership, not origin

    Its portfolio includes Cadbury, Oreo, and Toblerone — but none of those brands are owned outright in all markets; local licensing and joint ventures dilute control.

  6. 7:16
    The cost of being everywhere

    It operates globally but answers to no single jurisdiction — and uses that ambiguity to defer accountability on deforestation, child labour, and war-related operations.

3 more chaptersFewer chapters
Worth your time?

Yes. Study the whole thing.

3.5/ 5
What works
  • maintains billion-dollar brands across categories
  • generates $38.5bn revenue across ~160 countries
  • separates snack business from lower-margin grocery
What does not
  • resolve contradictions between global scale and ethical accountability
  • disclose how antitrust penalties relate to pricing or market conduct
  • end operations in Russia after the 2022 invasion
  • eliminate child labour or deforestation from its cocoa supply chain
Study it if
  • analysts studying corporate restructuring
  • students of food-system ethics
  • investors assessing ESG risk in consumer staples
Skip it if
  • founders seeking innovation playbooks
  • policy makers looking for regulatory models
  • consumers expecting ethical certification
Who should study it, and who should skipHide who it is for
The written brief1 min read

What the company or idea is

Mondelez International is an American multinational snack and confectionery company formed in 2012 when Kraft Foods Inc. was renamed and split. It inherited Kraft’s global snack business — including Oreo, Cadbury, Toblerone, and Ritz — while the North American grocery business became Kraft Foods Group.

How it actually makes money

Mondelez makes money by manufacturing and selling branded snack and confectionery products across approximately 160 countries. Its revenue is about $38.5 billion annually. It earns from cookies, biscuits, chocolate, gum, confectionery, and powdered beverages — not from licensing, services, or platforms.

What works

Its portfolio contains multiple billion-dollar brands across cookies, chocolate, and gum. Its global footprint — operating in ~160 countries — enables consistent revenue despite regional volatility. Its ownership of heritage brands like Cadbury and Oreo gives it pricing power and shelf dominance in mass-market channels.

What does not

Mondelez does not resolve the contradictions between its global scale and ethical accountability. It continues operations in Russia after the 2022 invasion. It faces documented allegations of deforestation and child labour in its cocoa supply chain. It pays antitrust penalties but does not disclose how those fines relate to pricing or market conduct.

What to take from it

Mondelez shows how corporate restructuring can separate financial performance from moral responsibility: it retains high-revenue brands while shedding liability-heavy categories and geographies — without changing core sourcing practices or governance.

Is it worth your time

Yes — if you want to understand how legacy food conglomerates restructure, extract value through brand consolidation, and manage reputational risk amid supply-chain controversies. No — if you expect innovation, margin expansion, or a coherent sustainability story.

Same desk · Companies4 of 325
11:29
Sun Pharma1983Sun Pharma is a vertically distributed generic drug manufacturer whose scale is real, verifiable, and geographically dispersed — but whose economics, margins, and strategic vulnerabilities remain undocumented in the source material.
9:31
PSA Group1976PSA Group was a French automotive manufacturer formed in 1976 when Peugeot took control of Citroën. It expanded through acquisition — Chrysler Europe (1978), Opel and Vauxhall (2017) — and alliances, notably with General Motors (2012). It rebranded as PSA Group in 2016 and attempted to re-enter North America, but merged with Fiat Chrysler Automobiles in 2021 to form Stellantis. Its strategy prioritised scale over self-sustaining regional operations.
10:59
Astellas Pharma2005Astellas Pharma is a Japanese multinational pharmaceutical company formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. It operates globally with R&D centers in Japan, the US, and the Netherlands, and has pursued an aggressive acquisition strategy since inception — including OSI Pharmaceuticals, Ocata Therapeutics, Audentes Therapeutics, and Iveric Bio — while also facing regulatory scrutiny over marketing practices and product safety issues.
9:12
Rimi Baltic2002Rimi Baltic is a Baltic-wide grocery retailer headquartered in Riga, founded in 1996 as SIA „Rimi Baltija“. It operates 317 stores and has distribution centres in Estonia, Latvia, and Lithuania. Its growth came via acquisition — ICA Gruppen bought it in 1998, then added Lithuania’s Ekovalda in 1999. Ownership shifted repeatedly: from ICA to a Kesko joint venture, back to ICA AB, then to Danish Salling Group in June 2025. Its strength is infrastructure; its weakness is narrative coherence.
Up next in Business

Morrisons

William Morrison · 1899 · 10:24

A century-old grocer built a national chain—then collapsed under private equity ownership the moment its pricing and scale advantages vanished.

10:24